Display options
Cite
He H, Ma D, Crone LB, et al. Assessment of the Drug-Drug Interaction Potential Between Theacrine and Caffeine in Humans. J Caffeine Res. 2017;7(3):95-102doi: 10.1089/jcr.2017.0006.
He, H., Ma, D., Crone, L. B., Butawan, M., Meibohm, B., Bloomer, R. J., & Yates, C. R. (2017). Assessment of the Drug-Drug Interaction Potential Between Theacrine and Caffeine in Humans. Journal of caffeine research, 7(3), 95-102. https://doi.org/10.1089/jcr.2017.0006
He, Hui, et al. "Assessment of the Drug-Drug Interaction Potential Between Theacrine and Caffeine in Humans." Journal of caffeine research vol. 7,3 (2017): 95-102. doi: https://doi.org/10.1089/jcr.2017.0006
He H, Ma D, Crone LB, Butawan M, Meibohm B, Bloomer RJ, Yates CR. Assessment of the Drug-Drug Interaction Potential Between Theacrine and Caffeine in Humans. J Caffeine Res. 2017 Sep 01;7(3):95-102. doi: 10.1089/jcr.2017.0006. PMID: 28875060; PMCID: PMC5582588.
Copy Download .nbib Format: NLM
Share it on

J Caffeine Res. 2017 Sep 01;7(3):95-102. doi: 10.1089/jcr.2017.0006.

Assessment of the Drug-Drug Interaction Potential Between Theacrine and Caffeine in Humans.

Journal of caffeine research

Hui He, Dejian Ma, Laura Brooks Crone, Matthew Butawan, Bernd Meibohm, Richard J Bloomer, Charles R Yates

Affiliations

  1. Department of Pharmaceutical Sciences, University of Tennessee College of Pharmacy, Memphis, Tennessee.
  2. Cardiorespiratory/Metabolic Laboratory, School of Health Studies, University of Memphis, Memphis, Tennessee.

PMID: 28875060 PMCID: PMC5582588 DOI: 10.1089/jcr.2017.0006

[No abstract available.]

Keywords: caffeine; pharmacokinetics; theacrine

Conflict of interest statement

R.J.B. and C.R.Y. have received research funding from Compound Solutions, Inc., including this study. These contracts paid for direct and indirect costs, as well as salary. This study was funded by Co

References

  1. Clin Pharmacol Ther. 2016 Dec;100(6):606-616 - PubMed
  2. J Sci Food Agric. 2015 Apr;95(6):1236-42 - PubMed
  3. J Agric Food Chem. 2013 Jul 3;61(26):6328-35 - PubMed
  4. NIDA Res Monogr. 1991;(116):213-29 - PubMed
  5. Ther Drug Monit. 2006 Jun;28(3):308-11 - PubMed
  6. Pharmacol Rep. 2008 Nov-Dec;60(6):789-97 - PubMed
  7. J Neurosci. 2002 Aug 1;22(15):6321-4 - PubMed
  8. J Neurosci. 1999 May 15;19(10):4011-22 - PubMed
  9. Handb Exp Pharmacol. 2011;(200):11-31 - PubMed
  10. Fitoterapia. 2010 Sep;81(6):627-31 - PubMed
  11. Food Chem. 2017 Feb 1;216:282-8 - PubMed
  12. J Pharmacokinet Biopharm. 1983 Apr;11(2):109-26 - PubMed
  13. Proc Natl Acad Sci U S A. 1989 Oct;86(20):7696-700 - PubMed
  14. Clin Pharmacol Ther. 2007 Jul;82(1):54-62 - PubMed
  15. J Int Soc Sports Nutr. 2016 Jan 13;13:2 - PubMed
  16. Phytochemistry. 2002 May;60(2):129-34 - PubMed
  17. Zhongguo Zhong Yao Za Zhi. 2013 Mar;38(5):753-6 - PubMed
  18. Pharmacol Biochem Behav. 2012 Aug;102(2):241-8 - PubMed
  19. J Neurochem. 2004 Nov;91(4):873-80 - PubMed
  20. Clin Pharmacol Ther. 2004 Apr;75(4):259-73 - PubMed
  21. J Toxicol. 2016;2016:6206859 - PubMed
  22. Alcohol Clin Exp Res. 2001 May;25(5 Suppl ISBRA):144S-151S - PubMed
  23. Neuropsychopharmacology. 2003 Oct;28(10):1752-9 - PubMed
  24. J Diet Suppl. 2016 May 10;:1-15 - PubMed
  25. Food Chem. 2013 Dec 1;141(3):2735-42 - PubMed
  26. J Asian Nat Prod Res. 2007 Sep-Dec;9(6-8):665-72 - PubMed
  27. Neuropsychopharmacology. 2003 Jul;28(7):1281-91 - PubMed
  28. Pharmacogenetics. 2002 Aug;12(6):473-8 - PubMed

Publication Types

Grant support